Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-18 Sale |
2024-10-22 4:18 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,570 | $30 | $47,104 | 188,245 (Indirect Direct) |
View |
| 2024-10-15 Sale |
2024-10-17 5:06 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $27.67 | $35,143 | 189,815 (Indirect Direct) |
View |
| 2024-10-04 Sale |
2024-10-08 6:54 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
2,825 | $27.51 | $77,704 | 191,085 (Indirect Direct) |
View |
| 2024-10-01 Sale |
2024-10-03 6:43 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
518 | $27.54 | $14,264 | 193,910 (Indirect Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 4:17 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $22.41 | $28,458 | 194,428 (Indirect Direct) |
View |
| 2024-08-15 Sale |
2024-08-19 7:49 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $23.25 | $29,526 | 195,698 (Indirect Direct) |
View |
| 2024-07-31 Sale |
2024-08-02 7:22 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
2,351 | $27.5 | $64,663 | 196,968 (Indirect Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 7:25 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $24.8 | $31,497 | 199,319 (Indirect Direct) |
View |
| 2024-06-17 Sale |
2024-06-20 7:20 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $21.48 | $27,278 | 200,589 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 7:46 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $23.74 | $30,150 | 201,859 (Indirect Direct) |
View |
| 2024-04-11 Sale |
2024-04-15 7:03 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
6,964 | $24.11 | $167,888 | 203,129 (Indirect Direct) |
View |
| 2024-03-19 Sale |
2024-03-21 6:41 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $14.5 | $18,419 | 210,093 (Indirect Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:59 pm |
RayzeBio Inc. | RYZB | Heyman Richard A. Director |
367,446 | $62.5 | $22,965,375 | 0 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 7:41 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $17.42 | $22,117 | 211,363 (Indirect Direct) |
View |
| 2024-01-30 Sale |
2024-02-01 8:10 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
1,270 | $16.41 | $20,840 | 212,633 (Indirect Direct) |
View |
| 2023-12-21 Sale |
2023-12-26 7:29 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
216 | $13 | $2,808 | 213,903 (Indirect Direct) |
View |
| 2023-12-19 Sale |
2023-12-21 4:28 pm |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
4,280 | $13.02 | $55,727 | 214,119 (Indirect Direct) |
View |
| 2021-09-14 Sale |
2021-09-16 6:19 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
1,388 | $25.04 | $34,760 | 228,772 (Indirect Direct) |
View |
| 2021-09-10 Sale |
2021-09-14 4:03 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
1,080 | $25.05 | $27,056 | 230,160 (Indirect Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 4:36 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
1,086 | $25.11 | $27,272 | 231,240 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-10 5:38 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
23,014 | $0 | 23,014 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:44 pm |
N/A 2035-01-01 |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:21 pm |
N/A 2034-06-11 |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
25,600 | $0 | 25,600 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:22 pm |
N/A 2034-06-05 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
67,500 | $0 | 67,500 (Direct) |
View |
| 2024-02-13 Option Award(A) |
2024-02-20 7:32 pm |
N/A 2034-02-13 |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
29,205 | $0 | 29,205 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:52 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
21,043 | $0 | 21,043 (Direct) |
View |
Ownership |
2023-09-14 7:26 pm |
N/A N/A |
RayzeBio Inc. | RYZB | Heyman Richard A. Director |
0 | $0 | 367,446 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:54 pm |
N/A 2033-06-13 |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 5:39 pm |
N/A 2033-06-07 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
21,500 | $0 | 21,500 (Direct) |
View |
| 2023-02-23 Option Award |
2023-04-06 8:19 pm |
N/A 2033-02-23 |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
34,458 | $0 | 34,458 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:54 pm |
N/A 2032-08-12 |
Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director |
239,056 | $0 | 201,649 (Direct) |
View |
| 2022-05-18 Option Award |
2022-09-06 7:23 pm |
N/A 2032-05-17 |
Metacrine Inc. | MTCR | Heyman Richard A. Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 5:32 pm |
N/A 2032-06-16 |
Gritstone bio Inc. | GRTS | Heyman Richard A. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-17 8:22 pm |
N/A 2032-06-16 |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
53,700 | $0 | 53,700 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:41 pm |
N/A 2032-06-01 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
19,500 | $0 | 19,500 (Direct) |
View |
| 2021-06-18 Option Award |
2021-11-19 4:57 pm |
N/A 2031-06-17 |
Gritstone bio Inc. | GRTS | Heyman Richard A. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-07-23 4:07 pm |
N/A 2031-05-11 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
5,781 | $0 | 5,781 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 7:46 pm |
N/A 2031-06-15 |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
16,625 | $0 | 16,625 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-09 5:30 pm |
N/A 2031-06-01 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
16,333 | $0 | 16,333 (Direct) |
View |